Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease

被引:3
|
作者
Mitchell, Jonathan [1 ]
Herrick-Reynolds, Kayleigh [2 ]
Motter, Jennifer D. [1 ]
Teles, Mayan [1 ]
Kates, Olivia [3 ]
Sung, Hannah [1 ]
Chen, Po-Hung [3 ]
King, Elizabeth [1 ]
Cameron, Andrew [1 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Surg, 720 Rutland Ave, Ross 765, Baltimore, MD 21205 USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 09期
基金
美国国家卫生研究院;
关键词
FOLLOW-UP; PREDICTORS; ABSTINENCE; RELAPSE;
D O I
10.1097/TXD.0000000000001532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT. Methods. A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email. Results. Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."Conclusions. More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients
    Shenoy, Akhil
    Salajegheh, Anna
    Shen, Nicole T.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 7
  • [32] Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
    Leko, Andras H.
    Leggio, Lorenzo
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 779 - 791
  • [33] Identification of Quantifiable Predictors of Relapse in Patients with Alcohol-Associated Liver Disease
    Shen, Nicole T.
    Kaplan, Alyson
    Fahoum, Khalid
    Basu, Elora
    Shenoy, Akhil
    Wahid, Nabeel
    Ivatorov, Amanda
    Pisa, Joseph
    Salajegheh, Annaheta
    Dawod, Enad
    Rosenblatt, Russell
    Fortune, Brett
    Safford, Monika
    Brown Jr, Robert S.
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (07) : 1156 - 1164
  • [34] Alcohol and other substance use after liver transplant
    Winder, Gerald Scott
    Shenoy, Akhil
    Dew, Mary Amanda
    DiMartini, Andrea F.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2020, 46-47
  • [35] Liver transplantation for alcoholic liver disease among Canadian transplant centres: A national study
    Chandok, Natasha
    Aljawad, Mohammed
    White, Angela
    Hernandez-Alejandro, Roberto
    Marotta, Paul
    Yoshida, Eric M.
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2013, 27 (11): : 643 - 646
  • [36] Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin
    Singal, Ashwani K.
    Leggio, Lorenzo
    DiMartini, Andrea
    LIVER TRANSPLANTATION, 2024, 30 (02) : 200 - 212
  • [37] Post-transplant complications in alcohol- and metabolic-associated steatotic liver disease
    Jadaun, Shekhar Singh
    Saigal, Sanjiv
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [38] Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease
    Desalegn, Hailemichael
    Farias, Renata
    Hudson, David
    Idalsoaga, Francisco
    Cabrera, Daniel
    Diaz, Luis Antonio
    Arab, Juan Pablo
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (03):
  • [39] Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
    Kulkarni, Anand, V
    Singal, Ashwani K.
    Kamath, Patrick S.
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 831 - 851
  • [40] Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder
    Vannier, Augustin G. L.
    Shay, Jessica E. S.
    Fomin, Vladislav
    Patel, Suraj J.
    Schaefer, Esperance
    Goodman, Russell P.
    Luther, Jay
    JAMA NETWORK OPEN, 2022, 5 (05) : E2213014